APDN launches SigNature DNA-based inks for pharma applications

28 February 2016 (Last Updated February 28th, 2016 18:30)

Applied DNA Sciences (APDN), a provider of botanical-DNA based security and authentication solutions and services, has launched SigNature DNA marker into new pharmaceutical-grade and packaging inks.

Applied DNA Sciences (APDN), a provider of botanical-DNA based security and authentication solutions and services, has launched SigNature DNA marker into new pharmaceutical-grade and packaging inks.

Launched in partnership with Nissha Printing and Kishu Giken Kogyo, the SigNature DNA can be used for tablet and packaging marking to offer authenticity and traceability for pharmaceutical global supply chains.

The SigNature DNA-based inks enable seamless marking at the point-of-manufacture.

"The scalability of SigNature DNA for pharmaceuticals solves many supply chain challenges as recently highlighted in Scientific American."

It will also ensure that original raw materials or ingredients used to produce pharmaceuticals are fully protected and traceable to point-of-sale.

SigNature DNA can also be used for other elements of a finished product including bulk active pharmaceutical ingredient (API), cellulosic excipients (bulk fillers) which are used in almost all drug tablets and the commercial binders and enteric coatings that hold prescription and over-the-counter (OTC) drug tablets together, APDN stated.

APDN president and CEO Dr James Hayward said: "The scalability of SigNature DNA for pharmaceuticals solves many supply chain challenges as recently highlighted in Scientific American.

"Many of our clients that are using SigNature DNA know that forensic tagging and authentication will protect them from the risk of legal liability and product recall while maintaining profitability and market differentiation."

APDN and its partners have tested and proved that SigNature DNA marks can be authenticated on the pharmaceutical tablet and packaging materials.